Clinical trial
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients (TITRATION)
The purpose of this study is to assess the safety and tolerability of initiating LCZ696 in heart failure patients with reduced ejection fraction (HF-rEF) using conservative (reaching target dose over 6 weeks) and condensed (reaching target dose over 3 weeks) up-titration regimens.
Category | Value |
---|---|
Study start date | 2013-08-12 |